Santero Therapeutics Email Formats

Biotechnology Research • Charleroi, Walloon Region, Belgium • 21-50 Employees

Santero Therapeutics Email Formats

Santero Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@santero.be), used 70.8% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@santero.be	70.8%
{first initial}.{last name}	j.doe@santero.be	29.2%

Key Contacts at Santero Therapeutics

Gokhan Batur

Non-Executive Chairman Of The Board Of Directors

Albert Palomer Benet

Member Board Of Directors

Bernard Scorneaux

Director Preclinical Development

Company overview

Headquarters	Rue Clément Ader 10, Charleroi, Walloon Region 6041, BE
Website	santero.be
NAICS	541714
Founded	2021
Employees	21-50
Socials

About Santero Therapeutics

Santero Therapeutics is developing an innovative approach to combating antimicrobial resistance (AMR), and antibiotic resistance in particular. The company wants to improve global health by developing innovative and safe antibiotics to eradicate multidrug-resistant deadly pathogens This field of research is one of the world's major public health challenges, as antimicrobial resistance (AMR) is one of the top ten threats to humanity, according to the United Nations. The number of deaths associated with AMR is estimated to be around 5 million per year worldwide in 2020, a figure that could double by 2050, and even reach several tens of millions of associated deaths according to recent scientific articles. Santero Therapeutic’s mission is to discover and validate first-in-class small molecules active against life-threatening multidrug-resistant pathogens. Its ambition is to set up a technological platform enabling the development of a whole range of new-generation antibiotics, effective against both Gram-positive bacteria (staphylococcus aureus, streptococcus, clostridium...) and Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae...), which present a serious public health problem, particularly in hospitals. The company is making rapid progress and is now entering the “lead optimization” phase, which is necessary before considering any human trials. Santero Therapeutics SRL is a spin-off of the Université Libre de Bruxelles (ULB) founded in 2021 by Professors Cédric Govaerts, PhD and Abel Garcia-Pino, PhD. Based in Mont-Saint-Guibert, it employs around fifteen people.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Santero Therapeutics has 12 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Santero Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-07	4	$8,600,000

Funding Insights

$8,600,000

Total funding amount

$8,600,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Santero Therapeutics is located in Charleroi, Walloon Region, BE.

Santero Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Santero Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Santero Therapeutics has raised a total of $8,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.